Mutant KRAS drives immune evasion by sensitizing cytotoxic T-cells to activation-induced cell death in colorectal cancer
In this study, 15 adult female Wistar rats were divided into three groups: control group, PCOS group receiving EV (4 mg/kg body weight), and PCOS group treated with LC administered orally by gavage (100 mg/kg daily for 17 days)
5a), a pro-drug that combines sulphapyridine (an antibiotic) and 5-aminosalicylic (an anti-inflammatory agent) linked by an azo bridge, has huge therapeutic potential, but is, unfortunately, labile under physiological conditions (70% degradation by colonic bacteria via azo cleavage
Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, et al